Methylene Blue Attenuates Diabetic Retinopathy by Inhibiting NLRP3 Inflammasome Activation in STZ-induced Diabetic Rats
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylene Blue Attenuates Diabetic Retinopathy by Inhibiting NLRP3 Inflammasome Activation in STZ-induced Diabetic Rats
Authors
Keywords
-
Journal
OCULAR IMMUNOLOGY AND INFLAMMATION
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2018-04-03
DOI
10.1080/09273948.2018.1450516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammasomes, the eye and anti-inflammasome therapy
- (2017) P Yerramothu et al. EYE
- Therapeutic Effect of Cilostazol Ophthalmic Nanodispersions on Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats
- (2017) Noriaki Nagai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction
- (2017) Yi Zhang et al. Cell Death & Disease
- Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy
- (2017) Po-Lin Liao et al. Scientific Reports
- Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation
- (2017) Huijeong Ahn et al. Scientific Reports
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
- (2016) Daniel Shu Wei Ting et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline
- (2016) Wei Chen et al. INFLAMMATION RESEARCH
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Diabetic Retinopathy: Mechanism, Diagnosis, Prevention, and Treatment
- (2015) Mohamed Al-Shabrawey et al. Biomed Research International
- Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats
- (2013) Yan-Fang Si et al. BRITISH JOURNAL OF PHARMACOLOGY
- The use of animal models in diabetes research
- (2012) Aileen JF King BRITISH JOURNAL OF PHARMACOLOGY
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- “Lest we forget you — methylene blue …”
- (2011) R. Heiner Schirmer et al. NEUROBIOLOGY OF AGING
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy
- (2010) L Perrone et al. Cell Death & Disease
- Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions
- (2009) Lorena Perrone et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search